Progyny reports Q4 revenue $298.4M (+10.6% YoY); FY2025 guidance $1.175-1.225B; corrects 2025 ART cycle outlook

Progyny, Inc.

2024-FY EPS reported $0.57 revenue$1,167,221,000

Q4 2024 revenue $298.4M (+10.6% YoY); net income $10.5M ($0.12 EPS); Adj. EBITDA $47.5M (15.9% margin).
FY2024 revenue $1.167B (+7.2%); net income $54.3M ($0.57 EPS); Adj. EBITDA $198.8M (17.0% margin).
FY2025 guidance: revenue $1.175-1.225B; Adj. EBITDA $188-201M; Adj. EPS $1.52-1.62.
Correction: 2025 ART cycle guidance revised to 61,600-64,300 from 59,350-61,850; no change to financial guidance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.